Common Variations of DNA Repair Genes are Associated with Response to Platinum-based Chemotherapy in NSCLCs |
Li, Xian-Dong
(Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Han, Ji-Chang (Department of Respiratory Medicine, Huaihe Hospital, Henan University) Zhang, Yi-Jie (Department of Respiratory Medicine, Huaihe Hospital, Henan University) Li, Hong-Bing (Department of Respiratory Medicine, Huaihe Hospital, Henan University) Wu, Xue-Yan (Department of Respiratory Medicine, Huaihe Hospital, Henan University) |
1 | Gurubhagavatula S, Liu G, Park S, et al (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-smallcell lung cancer patients treated with platinum chemotherapy. J Clin Oncol, 22, 2594-601. DOI ScienceOn |
2 | International Agency for Research on Cancer (2008). Lung cancer incidence, Mortality and Prevalence Worldwide in 2008. http://globocan.iarc.fr/factsheet.asp. |
3 | Lord RVN, Brabender J, Gandara D, et al (2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res, 8, 2286-91. |
4 | Lunn RM, Helzlsouer KJ, Parshad R, et al (2000). XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21, 551-5. DOI ScienceOn |
5 | Mi Y, Zhang L, Feng N, et al (2012). Impact of Two Common Xeroderma Pigmentosum Group D (XPD) Gene Polymorphisms on Risk of Prostate Cancer. PLoS One, 7, e44756. DOI |
6 | Monaco R, Rosal R, Dolan MA, et al (2009). Conformational effects of a common codon 751 polymorphism on the Cterminal domain of the xeroderma pigmentosum D protein. J Carcinog, 8, 12. DOI ScienceOn |
7 | J Carcinog, Provencio M, Camps C, Cobo M, et al (2012). Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. Cancer Chemother Pharmacol, 70, 883-90. DOI ScienceOn |
8 | Schiller JH, Harrington D, Belani CP, et al (2002). Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med, 346, 92-8. DOI ScienceOn |
9 | Spitz MR, Wu XF, Wang YF, et al (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res, 61, 1354-7. |
10 | Wei S-Z, Zhan P, Shi M, et al (2011). Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis. Med Oncol, 28, 315-21. DOI ScienceOn |
11 | William WN Jr, Lin HY, et al (2009). Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data. Chest, 136, 701-9. DOI ScienceOn |
12 | Wolfe KJ, Wickliffe JK, Hill CE, et al (2007). Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression. Pharmacogenet Genom, 17, 897-905. DOI |
13 | Wu Q, Christensen LA, Legerski RJ, et al (2005). Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. Embo Reports, 6, 551-6. DOI ScienceOn |
14 | Yin M, Yan J, Voutsina A, et al (2011). No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis. Lung Cancer, 72, 370-7. DOI ScienceOn |
15 | Zhang ZY, Tian X, Wu R, et al (2012). Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy. Asian Pac J Cancer Prev, 13, 2583-6. DOI ScienceOn |
16 | Ada AO, C Kunak S, Hancer F, et al (2010). CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma, 57, 512-21. DOI |
17 | Azuma K, Komohara Y, Sasada T, et al (2007) Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci, 98, 1336-43. DOI ScienceOn |
18 | Duan XL, Gong H, Zeng XT, et al (2012). Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 13, 3299-303. DOI ScienceOn |
19 | Butkiewicz D, Drosik A, Suwiński R, et al (2012). Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy. Int J Cancer, 131, E1100-8. DOI ScienceOn |